These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 11022134)
1. SDF-1-induced activation of ERK enhances HIV-1 expression. Montes M; Tagieva NE; Heveker N; Nahmias C; Baleux F; Trautmann A Eur Cytokine Netw; 2000 Sep; 11(3):470-7. PubMed ID: 11022134 [TBL] [Abstract][Full Text] [Related]
2. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Oberlin E; Amara A; Bachelerie F; Bessia C; Virelizier JL; Arenzana-Seisdedos F; Schwartz O; Heard JM; Clark-Lewis I; Legler DF; Loetscher M; Baggiolini M; Moser B Nature; 1996 Aug; 382(6594):833-5. PubMed ID: 8752281 [TBL] [Abstract][Full Text] [Related]
3. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Bleul CC; Farzan M; Choe H; Parolin C; Clark-Lewis I; Sodroski J; Springer TA Nature; 1996 Aug; 382(6594):829-33. PubMed ID: 8752280 [TBL] [Abstract][Full Text] [Related]
4. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013 [TBL] [Abstract][Full Text] [Related]
5. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies. Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150 [TBL] [Abstract][Full Text] [Related]
6. Loss of C-terminal alpha-helix decreased SDF-1alpha-mediated signaling and chemotaxis without influencing CXCR4 internalization. Cai SH; Tan Y; Ren XD; Li XH; Cai SX; Du J Acta Pharmacol Sin; 2004 Feb; 25(2):152-60. PubMed ID: 14769202 [TBL] [Abstract][Full Text] [Related]
7. Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/ CXCL12. Charnaux N; Brule S; Hamon M; Chaigneau T; Saffar L; Prost C; Lievre N; Gattegno L FEBS J; 2005 Apr; 272(8):1937-51. PubMed ID: 15819887 [TBL] [Abstract][Full Text] [Related]
9. The role of positively charged residues in CXCR4 recognition probed with synthetic peptides. Luo Z; Zhou N; Luo J; Hall JW; Huang Z Biochem Biophys Res Commun; 1999 Oct; 263(3):691-5. PubMed ID: 10512741 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat. Ghezzi S; Noonan DM; Aluigi MG; Vallanti G; Cota M; Benelli R; Morini M; Reeves JD; Vicenzi E; Poli G; Albini A Biochem Biophys Res Commun; 2000 Apr; 270(3):992-6. PubMed ID: 10772939 [TBL] [Abstract][Full Text] [Related]
11. Anti-HIV activity and conformational studies of peptides derived from the C-terminal sequence of SDF-1. Dettin M; Pasquato A; Scarinci C; Zanchetta M; De Rossi A; Di Bello C J Med Chem; 2004 Jun; 47(12):3058-64. PubMed ID: 15163187 [TBL] [Abstract][Full Text] [Related]
13. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4. Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179 [TBL] [Abstract][Full Text] [Related]
14. Different stereochemical requirements for CXCR4 binding and signaling functions as revealed by an anti-HIV, D-amino acid-containing SMM-chemokine ligand. Dong CZ; Kumar S; Choi WT; Madani N; Tian S; An J; Sodroski JG; Huang Z J Med Chem; 2005 Dec; 48(25):7923-4. PubMed ID: 16335916 [TBL] [Abstract][Full Text] [Related]
15. Regulation of CXCR4 receptor dimerization by the chemokine SDF-1alpha and the HIV-1 coat protein gp120: a fluorescence resonance energy transfer (FRET) study. Toth PT; Ren D; Miller RJ J Pharmacol Exp Ther; 2004 Jul; 310(1):8-17. PubMed ID: 15014135 [TBL] [Abstract][Full Text] [Related]
16. AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor. Hatse S; Princen K; De Clercq E; Rosenkilde MM; Schwartz TW; Hernandez-Abad PE; Skerlj RT; Bridger GJ; Schols D Biochem Pharmacol; 2005 Sep; 70(5):752-61. PubMed ID: 16011832 [TBL] [Abstract][Full Text] [Related]
17. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways. Huang CY; Lee CY; Chen MY; Yang WH; Chen YH; Chang CH; Hsu HC; Fong YC; Tang CH J Cell Physiol; 2009 Oct; 221(1):204-12. PubMed ID: 19496172 [TBL] [Abstract][Full Text] [Related]
18. Synergy between proinflammatory ligands of G protein-coupled receptors in neutrophil activation and migration. Gouwy M; Struyf S; Catusse J; Proost P; Van Damme J J Leukoc Biol; 2004 Jul; 76(1):185-94. PubMed ID: 15075362 [TBL] [Abstract][Full Text] [Related]
19. Increase of R5 HIV-1 infection and CCR5 expression in T cells treated with high concentrations of CXCR4 antagonists and SDF-1. Gotoh K; Yoshimori M; Kanbara K; Tamamura H; Kanamoto T; Mochizuki K; Fujii N; Nakashima H J Infect Chemother; 2001 Mar; 7(1):28-36. PubMed ID: 11406754 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of CD3/CD28-mediated activation of the MEK/ERK signaling pathway represses replication of X4 but not R5 human immunodeficiency virus type 1 in peripheral blood CD4(+) T lymphocytes. Popik W; Pitha PM J Virol; 2000 Mar; 74(6):2558-66. PubMed ID: 10684270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]